Polymorphism of tumor necrosis factor alpha (TNF-αlpha) gene promoter, circulating TNF-αlpha level, and cardiovascular risk factor for ischemic stroke

Journal of Neuroinflammation

Volumn 9, Issue 1, 2012, Pages

  Cui, Guanglin ^a   Wang, Haoran ^a   Li, Rui ^a   Zhang, Lina ^a   Li, Zongzhe ^a   Wang, Yan ^a   Hui, Rutai ^b   Ding, Hu ^a   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Cardiovascular risk factors; Function study; Genetics; Tumor necrosis factor alpha (TNF )

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIATION; HAN CHINESE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE; AGED; BLOOD; CASE CONTROL STUDY; CELL LINE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; GENOTYPE; ISCHEMIA; META ANALYSIS (TOPIC); MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE, TRANSFORMED; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISCHEMIA; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; STROKE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867209420     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-235     Document Type: Article

References (37)

1. Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38
2. Grau AJ, Buggle F, Becher H, Zimmermann E, Spiel M, Fent T, Maiwald M, Werle E, Zorn M, Hengel H, Hacke W: Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998, 50:196-203
3. Macko RF, Ameriso SF, Barndt R, Clough W, Weiner JM, Fisher M: Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 1996, 27:1999-2004
4. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of alzheimer's disease and vascular dementia: a case-control study. Lancet 2001, 357:436-439
5. Revilla M, Obach V, Cervera A, Davalos A, Castillo J, Chamorro A: A-174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 2002, 324:29-32
6. Hoppe C, Klitz W, D'Harlingue K, Cheng S, Grow M, Steiner L, Noble J, Adams R, Styles L: Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 2007, 38:2241-2246
7. Um JY, Lee JH, Joo JC, Kim KY, Lee EH, Shin T, Hong SH, Kim HM: Association between tumor necrosis factor-alpha gene polymorphism and Sasang constitution in cerebral infarction. Am J Chin Med 2005, 33:547-557
8. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ: Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997, 28:1233-1244
9. Wilson AG, Symons JA, McDowell TL, McDevitt HO, DuffGW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997, 94:3195-3199
10. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A: A common functional polymorphism (C→A substitution at position-863) in the promoter region of the tumour necrosis factoralpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999, 8:1443-1449
11. Kaijzel EL, van Krugten MV, Brinkman BM, Huizinga TW, van der Straaten T, Hazes JM, Ziegler-Heitbrock HW, Nedospasov SA, Breedveld FC, Verweij CL: Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998, 4:724-733
12. Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C: Functional study of TNF-alpha promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 2011, 22:88-102
13. Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE: Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. Am Heart J 2007, 153:821-830
14. Jefferis BJ, Whincup PH, Welsh P, Wannamethee SG, Rumley A, Lennon LT, Thomson AG, Carson C, Ebrahim S, Lowe GD: Circulating TNFalpha levels in older men and women do not show independent prospective relations with MI or stroke. Atherosclerosis 2009, 205:302-308
15. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695
16. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995, 37:800-805
17. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995, 26:1393-1398
18. Vila N, Filella X, Deulofeu R, Ascaso C, Abellana R, Chamorro A: Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 1999, 162:185-188
19. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG: Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 1999, 19:1004-1009
20. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A: Intrathecal release of pro-and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997, 110:492-499
21. Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang R, Bond MG, de Faire U, Nilsson J, Eriksson P, Hamsten A: Plasma tumour necrosis factoralpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 2002, 23:376-383
22. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M: Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003, 108:2317-2322
23. Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, Pacheco R, Bursac Z, Grant A, Mehta JL: Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007, 99:879-884
24. Ding H, Wu B, Wang H, Lu Z, Yan J, Wang X, Shaffer JR, Hui R, Wang DW: A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circ Res 2010, 106(6):1145-1152
25. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558
26. Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K: Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol 2009, 169:1158-1165
27. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634
28. Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B: Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol 2006, 35:488-495
29. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y: A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007, 39:212-217
30. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, Debette S, Lumley T, Folsom AR, van den Herik EG, Bos MJ, Beiser A, Cushman M, Launer LJ, Shahar E, Struchalin M, Du Y, Glazer NL, Rosamond WD, Rivadeneira F, Kelly-Hayes M, Lopez OL, Coresh J, Hofman A, DeCarli C, Heckbert SR, Koudstaal PJ, Yang Q, Smith NL, Kase CS, et al: Genomewide association studies of stroke. N Engl J Med 2009, 360:1718-1728
31. Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N, Yoshida H, Satoh K, Kato K, Watanabe S, Nozawa Y, Hasegawa A, Kojima T: Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 2009, 207:144-149
32. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, Kostulas K, Kuhlenbaumer G, Bevan S, Jonsdottir T, Bjarnason H, Saemundsdottir J, Palsson S, Arnar DO, Holm H, Thorgeirsson G, Valdimarsson EM, Sveinbjornsdottir S, Gieger C, Berger K, Wichmann HE, Hillert J, Markus KH, Gulcher JR, Ringelstein EB, Kong A, Dichgans M, Gudbjartsson DF, Thorsteindottir U, Stefansson K: Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 2008, 64:402-409
33. Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung HC, Hernandez D, Gibbs JR, De Vrieze FW, Crews C, Britton A, Langefeld CD, Brott TG, Brown RD Jr, Worrall BB, Frankel M, Silliman S, Case LD, Singleton A, Hardy JA, Rich SS, Meschia JF: A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 2007, 6:414-420
34. International Stroke Genetics Consortium (ISGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, Jackson CA, Traylor M, Strange A, Su Z, Band G, Syme PD, Malik R, Pera J, Norvving B, Lemmens R, Freeman C, Schanz R, James T, Poole D, Murphy L, Segal H, Cortellini L, Cheng YC, Woo D, Nails MA, Muller-Myhsok B, Meisinger C, Seedorf U, Ross-Adams H, et al: Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012, 44:328-333
35. Freilinger T, Bevan S, Ripke S, Gschwendtner A, Lichtner P, Muller-Myhsok B, Wichmann HE, Markus HS, Meitinger T, Dichgans M: Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in European populations. Stroke 2009, 40:970-972
36. Welsh P, Woodward M, Rumley A, Lowe G: Associations of plasma proinflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008, 141:852-861
37. Egger M, Smith GD: Misleading meta-analysis. BMJ 1995, 310:752-754